Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2013. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial performance data.
Material Changes
The filing details a specific transaction on July 9, 2013, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. They acquired a total of 4 Ordinary Shares through the Company's ShareReward Plan at a price of 1,737.56 pence per share. The acquisition consisted of 2 shares under the personal contribution element and 2 shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of a director's share purchase.
Key Facts for Investor Verification
- Transaction Date: July 9, 2013.
- Price per Share: 1,737.56 pence.
- Parties Involved: Mr. P C Thomson and Mrs. K Thomson.
- Total Shares Acquired: 4 Ordinary Shares (2 personal, 2 company match).
- Notification Date: July 10, 2013.